Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.395 USD | -0.11% | +1.40% | +142.22% |
03-22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
03-21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+142.22% | 259M | |
-1.34% | 104B | |
+3.98% | 97.47B | |
+5.50% | 22.25B | |
-13.53% | 21.68B | |
-9.44% | 18.2B | |
-39.98% | 17.02B | |
-11.57% | 16.36B | |
+8.40% | 14.39B | |
+41.24% | 12.37B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- Insider Buy: Pyxis Oncology